Ocular allergy Latin American consensus

Arquivos brasileiros de oftalmologia
Myrna Serapião dos SantosJosé Álvaro Pereira Gomes

Abstract

To establish current definition, classification and staging, and to develop diagnosis and treatment recommendations for ocular allergy, by using Delphi approach. Ten Latin American experts on ocular allergy participated in a 4-round Delphi panel approach. Four surveys were constructed and answered by panelists. A two-thirds majority was defined as consensus. Definition, classification, staging and diagnosis and treatment recommendations were the main outcomes. "Ocular allergy" was proposed as the general term to describe ocular allergic diseases. Consensus regarding classification was not reached. Signs and symptoms were considered extremely important for the diagnosis. It was consensus that a staging system should be proposed based on the disease severity. Environmental control, avoidance of allergens and the use of artificial tears were recommended as first line treatment. The secondary treatment should include topical anti-histamines, mast cell stabilizers and multi actions drugs. Topical non-steroidal anti-inflammatory and vasoconstrictors were not recommended. Topical corticosteroids were recommended as third line of treatment for the most severe keratoconjunctivitis. Consensus was not reached regarding the use of systemic...Continue Reading

Citations

Jul 15, 2015·Cornea·Júlia Gomes Fernandes PolidoPedro Durães Serracarbassa
Mar 5, 2015·Cornea·José A P GomesUNKNOWN Group of Panelists for the Global Delphi Panel of Keratoconus and Ectatic Diseases
Jan 15, 2014·Eye & Contact Lens·Guilherme Gubert MüllerRosane Silvestre de Castro
May 11, 2017·Asia Pacific Allergy·Bernard Yu-Hor Thong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.